MDxHealth SA SEC filings MDXH

MDxHealth SA has 183 filings in SEC EDGAR's recent list, going back to Aug 9, 2021. Its latest annual report, Form 20-F, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026.

MDxHealth SA SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 30, 2026 Oct 30, 2026
6-K Current report (foreign issuer) Oct 16, 2026 Oct 16, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 15, 2026 —
144 Notice of proposed sale Sep 17, 2026 —
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 17, 2026 —
4 Insider transaction Aug 17, 2026 Aug 13, 2026
SCHEDULE 13D Ownership over 5% (active) Aug 14, 2026 —
6-K Current report (foreign issuer) Aug 13, 2026 Aug 13, 2026
424B5 Prospectus supplement Aug 13, 2026 —
6-K Current report (foreign issuer) Aug 13, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
6-K Current report (foreign issuer) Jul 24, 2026 Jul 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 8, 2026 —
6-K Current report (foreign issuer) Jul 2, 2026 Jul 2, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
3 Initial insider ownership May 28, 2026 May 18, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) Apr 30, 2026 Apr 29, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 9, 2026 Mar 18, 2026
3 Initial insider ownership Apr 9, 2026 Mar 18, 2026
3 Initial insider ownership Apr 9, 2026 Mar 18, 2026
S-8 Employee stock plan registration Apr 3, 2026 —
20-F Annual report (foreign issuer) Apr 3, 2026 Dec 31, 2025
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Feb 26, 2026 Feb 26, 2026
EFFECT Filing Feb 17, 2026 —
CORRESP Letter to the SEC Feb 12, 2026 —
F-3/A Amendment no.1 to form f-3 Feb 11, 2026 —
6-K Current report (foreign issuer) Feb 11, 2026 Feb 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 16, 2026 —
6-K Current report (foreign issuer) Jan 12, 2026 Jan 12, 2026
UPLOAD Letter from the SEC Jan 6, 2026 —
F-3 Shelf registration (foreign issuer) Dec 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
6-K Current report (foreign issuer) Nov 12, 2025 Nov 12, 2025
6-K Current report (foreign issuer) Sep 16, 2025 Sep 15, 2025
6-K Current report (foreign issuer) Aug 14, 2025 Aug 14, 2025
6-K Current report (foreign issuer) Aug 5, 2025 Aug 5, 2025
6-K Current report (foreign issuer) Jul 3, 2025 Jul 3, 2025
6-K Current report (foreign issuer) Jun 6, 2025 Jun 6, 2025
6-K Current report (foreign issuer) May 14, 2025 May 14, 2025
6-K Current report (foreign issuer) May 6, 2025 May 5, 2025
6-K Current report (foreign issuer) May 2, 2025 May 2, 2025
20-F Annual report (foreign issuer) Mar 31, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 21, 2025 —
6-K Current report (foreign issuer) Mar 7, 2025 Mar 7, 2025
6-K Current report (foreign issuer) Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
6-K Current report (foreign issuer) Jan 13, 2025 Jan 13, 2025
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
6-K Current report (foreign issuer) Nov 6, 2024 Nov 6, 2024
6-K Current report (foreign issuer) Oct 29, 2024 Oct 29, 2024
SC 13D/A Amended ownership over 5% (active) Oct 28, 2024 —
SC 13G Ownership over 5% (passive) Oct 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 4, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 3, 2024 —
6-K Current report (foreign issuer) Sep 30, 2024 Sep 30, 2024
424B5 Prospectus supplement Sep 26, 2024 —
424B5 Prospectus supplement Sep 25, 2024 —
6-K Current report (foreign issuer) Aug 21, 2024 Aug 21, 2024
EFFECT Filing Jul 10, 2024 —
CORRESP Letter to the SEC Jul 8, 2024 —
6-K Current report (foreign issuer) Jul 8, 2024 Jul 8, 2024
F-3/A Amendment no. 1 to form f-3 Jul 3, 2024 —
UPLOAD Letter from the SEC Jul 2, 2024 —
F-3 Shelf registration (foreign issuer) Jun 28, 2024 —
6-K Current report (foreign issuer) Jun 20, 2024 Jun 20, 2024
6-K Current report (foreign issuer) Jun 5, 2024 Jun 5, 2024
6-K Current report (foreign issuer) May 16, 2024 May 16, 2024
6-K Current report (foreign issuer) May 6, 2024 May 6, 2024
6-K Current report (foreign issuer) May 1, 2024 May 1, 2024
6-K Current report (foreign issuer) May 1, 2024 May 1, 2024
424B5 Prospectus supplement Apr 30, 2024 —
20-F Annual report (foreign issuer) Apr 30, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 12, 2024 Mar 12, 2024
6-K Current report (foreign issuer) Mar 6, 2024 Mar 6, 2024
6-K Current report (foreign issuer) Feb 16, 2024 Feb 16, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
6-K Current report (foreign issuer) Jan 8, 2024 Jan 8, 2024
6-K Current report (foreign issuer) Dec 19, 2023 Dec 19, 2023
6-K Current report (foreign issuer) Nov 27, 2023 Nov 27, 2023
8-A12B/A Amendment no. 1 to form 8-a12b Nov 24, 2023 —
25-NSE Delisting notice Nov 24, 2023 —
6-K Current report (foreign issuer) Nov 15, 2023 Nov 15, 2023
6-K Current report (foreign issuer) Nov 13, 2023 Nov 13, 2023
6-K Current report (foreign issuer) Nov 8, 2023 Nov 8, 2023
6-K Current report (foreign issuer) Nov 8, 2023 Nov 8, 2023
6-K Current report (foreign issuer) Nov 6, 2023 Nov 6, 2023
6-K Current report (foreign issuer) Oct 23, 2023 Oct 23, 2023
6-K Current report (foreign issuer) Oct 11, 2023 Oct 11, 2023
6-K Current report (foreign issuer) Oct 10, 2023 Oct 10, 2023
6-K Current report (foreign issuer) Oct 3, 2023 Oct 3, 2023
6-K Current report (foreign issuer) Aug 23, 2023 Aug 23, 2023
6-K Current report (foreign issuer) Aug 10, 2023 Aug 10, 2023
6-K Current report (foreign issuer) Jul 5, 2023 Jul 5, 2023
6-K Current report (foreign issuer) Jul 3, 2023 Jul 3, 2023
6-K Current report (foreign issuer) Jun 6, 2023 Jun 6, 2023
6-K Current report (foreign issuer) May 26, 2023 May 26, 2023
6-K Current report (foreign issuer) May 15, 2023 May 15, 2023
6-K Current report (foreign issuer) Apr 26, 2023 Apr 26, 2023
20-F Annual report (foreign issuer) Apr 25, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Apr 20, 2023 Apr 20, 2023
SC 13D/A Amended ownership over 5% (active) Apr 14, 2023 —
6-K Current report (foreign issuer) Apr 14, 2023 Apr 14, 2023
SC 13G/A Amended ownership over 5% (passive) Mar 17, 2023 —
6-K Current report (foreign issuer) Mar 9, 2023 Mar 8, 2023
4 Insider transaction Feb 28, 2023 Feb 3, 2023
SC 13D/A Amended ownership over 5% (active) Feb 28, 2023 —
6-K Current report (foreign issuer) Feb 23, 2023 Feb 22, 2023
6-K Current report (foreign issuer) Feb 15, 2023 Feb 15, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
6-K Current report (foreign issuer) Feb 9, 2023 Feb 9, 2023
424B5 Prospectus supplement Feb 6, 2023 —
424B5 Prospectus supplement Feb 1, 2023 —
6-K Current report (foreign issuer) Jan 20, 2023 Jan 20, 2023
6-K Current report (foreign issuer) Jan 9, 2023 Jan 9, 2023
EFFECT Filing Dec 30, 2022 —
CORRESP Letter to the SEC Dec 28, 2022 —
UPLOAD Letter from the SEC Dec 27, 2022 —
F-3 Shelf registration (foreign issuer) Dec 19, 2022 —
6-K Current report (foreign issuer) Dec 19, 2022 Dec 19, 2022
6-K Current report (foreign issuer) Nov 29, 2022 Nov 29, 2022
SC 13D/A Amended ownership over 5% (active) Nov 23, 2022 —
6-K Current report (foreign issuer) Oct 27, 2022 Oct 27, 2022
6-K Current report (foreign issuer) Aug 26, 2022 Aug 26, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Aug 25, 2022
6-K Current report (foreign issuer) Aug 19, 2022 Aug 19, 2022
D Filing Aug 15, 2022 —
6-K Current report (foreign issuer) Aug 2, 2022 Aug 2, 2022
6-K Current report (foreign issuer) May 27, 2022 May 27, 2022
6-K Current report (foreign issuer) May 20, 2022 May 20, 2022
6-K Current report (foreign issuer) May 6, 2022 May 6, 2022
6-K Current report (foreign issuer) Apr 28, 2022 Apr 28, 2022
6-K Current report (foreign issuer) Apr 27, 2022 Apr 27, 2022
20-F Annual report (foreign issuer) Apr 25, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Mar 3, 2022 Mar 3, 2022
SC 13G Ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13D Ownership over 5% (active) Dec 27, 2021 —
6-K Current report (foreign issuer) Dec 13, 2021 Dec 13, 2021
SC 13D Ownership over 5% (active) Dec 1, 2021 —
3 Initial insider ownership Nov 30, 2021 Nov 4, 2021
6-K Current report (foreign issuer) Nov 23, 2021 Nov 22, 2021
6-K Current report (foreign issuer) Nov 15, 2021 Nov 15, 2021
SC 13G Ownership over 5% (passive) Nov 12, 2021 —
6-K Current report (foreign issuer) Nov 9, 2021 Nov 9, 2021
424B4 Prospectus Nov 5, 2021 —
SEC STAFF LETTER Filing Nov 4, 2021 —
EFFECT Filing Nov 3, 2021 —
CERT Filing Nov 3, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
8-A12B For registration of certain classes Nov 1, 2021 —
F-1/A Amendment no. 2 to form f-1 Nov 1, 2021 —
CORRESP Letter to the SEC Nov 1, 2021 —
UPLOAD Letter from the SEC Oct 29, 2021 —
F-1/A Registration statement Oct 28, 2021 —
CORRESP Letter to the SEC Oct 13, 2021 —
F-1 Registration statement (foreign issuer) Oct 13, 2021 —
UPLOAD Letter from the SEC Oct 8, 2021 —
DRS/A Filing Sep 23, 2021 —
DRSLTR Filing Sep 22, 2021 —
SEC STAFF LETTER Filing Sep 10, 2021 —
UPLOAD Letter from the SEC Sep 7, 2021 —
DRS Filing Aug 9, 2021 —

Showing 183 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
MDXH (Nasdaq)
Incorporated in
Belgium
Headquarters
Herstal, Belgium
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1872529

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.